$HFBL
Home Federal Bancorp, Inc. of Louisiana

2023 Q4 Form 10-Q Financial Statement

#000114036123052977 Filed on November 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $8.080M $8.074M
YoY Change 32.72% 39.66%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $129.0K $245.0K
YoY Change -41.36% 35.36%
% of Gross Profit
Depreciation & Amortization $436.0K $224.0K
YoY Change 104.69% 2.75%
% of Gross Profit
Operating Expenses $129.0K $245.0K
YoY Change -41.36% 35.36%
Operating Profit
YoY Change
Interest Expense $3.177M $2.790M
YoY Change 315.84% 486.13%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $807.0K $1.530M
YoY Change -62.59% -8.93%
Income Tax -$196.0K $310.0K
% Of Pretax Income -24.29% 20.26%
Net Earnings $1.003M $1.220M
YoY Change -41.45% -26.99%
Net Earnings / Revenue 12.41% 15.11%
Basic Earnings Per Share $0.33 $0.40
Diluted Earnings Per Share $0.33 $0.39
COMMON SHARES
Basic Shares Outstanding 3.133M 3.133M
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $8.668M $8.878M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $17.61M $16.98M
YoY Change 9.43% 5.21%
Goodwill $2.990M $2.990M
YoY Change
Intangibles $1.354M $1.439M
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.173M $1.500M
YoY Change -19.71% 2.32%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $654.2M $662.6M
YoY Change 13.47% 13.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $2.510M $5.500M
YoY Change 19.47% 81.1%
Deferred Revenue
YoY Change
Short-Term Debt $9.995M $9.600M
YoY Change 48.56% 40.35%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $12.50M $15.10M
YoY Change 495.19% 397.2%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $12.50M $15.10M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $601.6M $612.1M
YoY Change 13.97% 14.53%
SHAREHOLDERS EQUITY
Retained Earnings $13.93M $13.35M
YoY Change 24.94% 35.07%
Common Stock $31.00K $31.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $52.59M $50.47M
YoY Change
Total Liabilities & Shareholders Equity $654.2M $662.6M
YoY Change 13.47% 13.93%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $1.003M $1.220M
YoY Change -41.45% -26.99%
Depreciation, Depletion And Amortization $436.0K $224.0K
YoY Change 104.69% 2.75%
Cash From Operating Activities -$2.640M $2.445M
YoY Change -480.4% -43.6%
INVESTING ACTIVITIES
Capital Expenditures $860.0K $660.0K
YoY Change 424.39% -722.64%
Acquisitions
YoY Change
Other Investing Activities $11.19M -$17.49M
YoY Change -195.9% -14.77%
Cash From Investing Activities $10.33M -$18.15M
YoY Change -187.3% -12.03%
FINANCING ACTIVITIES
Cash Dividend Paid $392.0K
YoY Change -3.69%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -7.893M -187.0K
YoY Change 32.66% -98.18%
NET CHANGE
Cash From Operating Activities -2.640M 2.445M
Cash From Investing Activities 10.33M -18.15M
Cash From Financing Activities -7.893M -187.0K
Net Change In Cash -207.0K -15.89M
YoY Change -98.79% -40.16%
FREE CASH FLOW
Cash From Operating Activities -$2.640M $2.445M
Capital Expenditures $860.0K $660.0K
Free Cash Flow -$3.500M $1.785M
YoY Change -760.38% -59.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Liabilities
Liabilities
610373000
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
31000
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
31000
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
41057000
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
40981000
CY2023Q3 us-gaap Interest Expense
InterestExpense
2790000
CY2023Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
5284000
CY2022Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
4887000
CY2023Q3 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
38000
CY2023Q3 hfbl Unearned Esop Shares Cost
UnearnedESOPSharesCost
495000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
50473000
CY2022Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
5028000
CY2023Q3 us-gaap Investment Income Net
InvestmentIncomeNet
150000
CY2023Q3 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
473000
CY2022Q3 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
489000
CY2023Q3 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
177000
CY2022Q3 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
262000
CY2022Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
5781000
CY2023Q3 us-gaap Interest Expense Deposits
InterestExpenseDeposits
2592000
CY2023Q3 us-gaap Interest Expense Other Long Term Debt
InterestExpenseOtherLongTermDebt
15000
CY2022Q3 us-gaap Interest Expense Other Long Term Debt
InterestExpenseOtherLongTermDebt
10000
CY2023Q3 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm
183000
CY2022Q3 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm
66000
CY2023Q3 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
26000
CY2022Q3 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
26000
CY2023Q3 hfbl Service Charges On Deposit Accounts
ServiceChargesOnDepositAccounts
391000
CY2022Q3 hfbl Service Charges On Deposit Accounts
ServiceChargesOnDepositAccounts
335000
CY2023Q3 us-gaap Noninterest Income Other
NoninterestIncomeOther
13000
CY2022Q3 us-gaap Noninterest Income Other
NoninterestIncomeOther
10000
CY2023Q3 us-gaap Noninterest Income
NoninterestIncome
434000
CY2022Q3 us-gaap Noninterest Income
NoninterestIncome
546000
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2356000
CY2022Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2282000
CY2023Q3 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
245000
CY2022Q3 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
181000
CY2023Q3 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
156000
CY2022Q3 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
119000
CY2023Q3 us-gaap Advertising Expense
AdvertisingExpense
143000
CY2023Q3 us-gaap Loan Portfolio Expense
LoanPortfolioExpense
60000
CY2022Q3 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
47000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.4
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.55
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1671000
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-1028000
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-1109000
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-216000
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-231000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-812000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
408000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
50542000
CY2023Q2 hfbl Unearned Esop Shares Cost
UnearnedESOPSharesCost
523000
CY2023Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
7274000
CY2023Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
8074000
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
5284000
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
5305000
CY2023Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
0
CY2022Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
418000
CY2023Q3 us-gaap Occupancy Net
OccupancyNet
549000
CY2022Q3 us-gaap Advertising Expense
AdvertisingExpense
74000
CY2022Q3 us-gaap Loan Portfolio Expense
LoanPortfolioExpense
52000
CY2023Q3 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
91000
CY2023Q3 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
1557000
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
40409000
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
39551000
CY2023Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
57557000
CY2023Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
61222000
CY2023Q3 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
72806000
CY2023Q2 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
74423000
CY2023Q3 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
589000
CY2023Q2 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
4000
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5102000
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5173000
CY2023Q3 us-gaap Notes Receivable Net
NotesReceivableNet
506599000
CY2023Q2 us-gaap Notes Receivable Net
NotesReceivableNet
489493000
CY2023Q3 us-gaap Interest Receivable
InterestReceivable
1907000
CY2023Q2 us-gaap Interest Receivable
InterestReceivable
1790000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16978000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16561000
CY2023Q3 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
6725000
CY2023Q2 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
6700000
CY2023Q3 us-gaap Assets
Assets
662602000
CY2023Q2 us-gaap Assets
Assets
660915000
CY2023Q3 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
146057000
CY2023Q2 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
145553000
CY2023Q3 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
446448000
CY2023Q2 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
451808000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
660915000
CY2023Q3 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
8878000
CY2023Q2 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
24765000
CY2023Q3 us-gaap Goodwill
Goodwill
2990000
CY2023Q2 us-gaap Goodwill
Goodwill
2990000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1439000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1533000
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1313000
CY2023Q2 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
368000
CY2023Q2 us-gaap Other Assets
OtherAssets
1424000
CY2023Q3 us-gaap Deposits
Deposits
592505000
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
13346000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2654000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
662602000
CY2023Q2 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
145553000
CY2023Q3 us-gaap Deposits Negotiable Order Of Withdrawal Now
DepositsNegotiableOrderOfWithdrawalNOW
63613000
CY2023Q2 us-gaap Deposits Negotiable Order Of Withdrawal Now
DepositsNegotiableOrderOfWithdrawalNOW
65335000
CY2023Q3 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
104580000
CY2023Q2 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
114195000
CY2023Q3 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
75747000
CY2023Q2 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
81895000
CY2023Q3 hfbl Transaction Accounts Amount
TransactionAccountsAmount
389997000
CY2023Q2 hfbl Transaction Accounts Amount
TransactionAccountsAmount
406978000
CY2023Q3 us-gaap Time Deposits
TimeDeposits
202508000
CY2023Q2 us-gaap Time Deposits
TimeDeposits
190383000
CY2023Q3 us-gaap Deposits
Deposits
592505000
CY2023Q2 us-gaap Deposits
Deposits
597361000
CY2023Q3 dei Amendment Flag
AmendmentFlag
false
CY2023Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2023Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001500375
CY2023Q2 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
22215000
CY2023Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
44736000
CY2023Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
42910000
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1460000
CY2023Q3 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
561000
CY2023Q3 us-gaap Other Assets
OtherAssets
1261000
CY2023Q2 us-gaap Deposits
Deposits
597361000
CY2023Q3 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
715000
CY2023Q2 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
554000
CY2023Q3 us-gaap Federal Home Loan Bank Advances Maturities Summary Due Within One Year Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueWithinOneYearOfBalanceSheetDate
4600000
CY2023Q2 us-gaap Federal Home Loan Bank Advances Maturities Summary Due Within One Year Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueWithinOneYearOfBalanceSheetDate
0
CY2023Q3 us-gaap Line Of Credit
LineOfCredit
8850000
CY2023Q2 us-gaap Line Of Credit
LineOfCredit
8550000
CY2023Q3 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
5459000
CY2023Q2 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
3908000
CY2023Q3 us-gaap Liabilities
Liabilities
612129000
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3133351
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3133351
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3133351
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3133351
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
12707000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3466000
CY2022Q3 us-gaap Investment Income Net
InvestmentIncomeNet
2000
CY2022Q3 us-gaap Interest Expense Deposits
InterestExpenseDeposits
400000
CY2022Q3 us-gaap Interest Expense
InterestExpense
476000
CY2022Q3 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
175000
CY2023Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-34000
CY2022Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
CY2022Q3 us-gaap Occupancy Net
OccupancyNet
501000
CY2023Q3 hfbl Audit And Examination Fees
AuditAndExaminationFees
102000
CY2022Q3 hfbl Audit And Examination Fees
AuditAndExaminationFees
75000
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
160000
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
126000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
94000
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0
CY2023Q3 us-gaap Other Noninterest Expense
OtherNoninterestExpense
232000
CY2022Q3 us-gaap Other Noninterest Expense
OtherNoninterestExpense
296000
CY2023Q3 us-gaap Noninterest Expense
NoninterestExpense
4188000
CY2022Q3 us-gaap Noninterest Expense
NoninterestExpense
3753000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1530000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1680000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
310000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1220000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1671000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1220000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-878000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
793000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
52347000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1671000
CY2022Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
878000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
26000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
147000
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
111000
CY2022Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
5892000
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2022Q3 us-gaap Dividends
Dividends
407000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
47125000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
50542000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1220000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
23000
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
81000
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.13
CY2023Q3 us-gaap Dividends
Dividends
392000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
50473000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1220000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1671000
CY2023Q3 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
38000
CY2022Q3 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
175000
CY2023Q3 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-107000
CY2022Q3 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-3000
CY2023Q3 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
33000
CY2022Q3 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
194000
CY2023Q3 hfbl Amortization Of Purchased Loans
AmortizationOfPurchasedLoans
-419000
CY2022Q3 hfbl Amortization Of Purchased Loans
AmortizationOfPurchasedLoans
0
CY2023Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
0
CY2022Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
418000
CY2023Q3 us-gaap Depreciation
Depreciation
224000
CY2022Q3 us-gaap Depreciation
Depreciation
218000
CY2023Q3 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-34000
CY2022Q3 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
0
CY2023Q3 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
81000
CY2022Q3 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
111000
CY2023Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
23000
CY2022Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
26000
CY2023Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-147000
CY2022Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-323000
CY2023Q3 hfbl Federal Home Loan Bank Stock Dividend
FederalHomeLoanBankStockDividend
-17000
CY2022Q3 hfbl Federal Home Loan Bank Stock Dividend
FederalHomeLoanBankStockDividend
-1000
CY2023Q3 hfbl Share Awards Expense
ShareAwardsExpense
28000
CY2022Q3 hfbl Share Awards Expense
ShareAwardsExpense
31000
CY2023Q3 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
26000
CY2022Q3 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
26000
CY2023Q3 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
362000
CY2022Q3 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
1000
CY2023Q3 us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
1807000
CY2022Q3 us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
9932000
CY2023Q3 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
1222000
CY2022Q3 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
12097000
CY2023Q3 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
117000
CY2022Q3 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
126000
CY2023Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-163000
CY2022Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-103000
CY2023Q3 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1551000
CY2022Q3 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
431000
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2445000
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4335000
CY2023Q3 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
17659000
CY2022Q3 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
18717000
CY2023Q3 hfbl Proceeds From Deferred Loan Fees Collected
ProceedsFromDeferredLoanFeesCollected
16000
CY2022Q3 hfbl Proceeds From Deferred Loan Fees Collected
ProceedsFromDeferredLoanFeesCollected
93000
CY2023Q3 hfbl Payments To Acquire Buildings And Equipment
PaymentsToAcquireBuildingsAndEquipment
656000
CY2022Q3 hfbl Payments To Acquire Buildings And Equipment
PaymentsToAcquireBuildingsAndEquipment
106000
CY2023Q3 us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
276000
CY2022Q3 us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
0
CY2023Q3 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
38000
CY2022Q3 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
0
CY2023Q3 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
952000
CY2022Q3 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
1610000
CY2023Q3 hfbl Payments To Acquire Municipal Bonds
PaymentsToAcquireMunicipalBonds
0
CY2022Q3 hfbl Payments To Acquire Municipal Bonds
PaymentsToAcquireMunicipalBonds
570000
CY2023Q3 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
2667000
CY2022Q3 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
4806000
CY2023Q3 hfbl Payments To Acquire Us Treasury Notes
PaymentsToAcquireUSTreasuryNotes
0
CY2022Q3 hfbl Payments To Acquire Us Treasury Notes
PaymentsToAcquireUSTreasuryNotes
0
CY2023Q3 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
0
CY2022Q3 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
0
CY2023Q3 us-gaap Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
0
CY2022Q3 us-gaap Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
0
CY2023Q3 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
1631000
CY2022Q3 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
1870000
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18145000
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20626000
CY2023Q3 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-4856000
CY2022Q3 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-8231000
CY2023Q3 us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
77100000
CY2022Q3 us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
0
CY2023Q3 us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
72500000
CY2022Q3 us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
9000
CY2023Q3 us-gaap Payments Of Dividends
PaymentsOfDividends
392000
CY2022Q3 us-gaap Payments Of Dividends
PaymentsOfDividends
407000
CY2023Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
CY2022Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5892000
CY2023Q3 us-gaap Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
161000
CY2022Q3 us-gaap Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
136000
CY2023Q3 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
300000
CY2022Q3 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
4000000
CY2023Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2022Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
147000
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-187000
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10256000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-15887000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-26547000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24765000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
64078000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8878000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37531000
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
2772000
CY2022Q3 us-gaap Interest Paid Net
InterestPaidNet
468000
CY2023Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent
812000
CY2022Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent
1109000
CY2023Q3 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
465000
CY2022Q3 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
93000
CY2023Q2 us-gaap Trading Securities
TradingSecurities
0
CY2023Q3 us-gaap Trading Securities
TradingSecurities
0
CY2023Q3 hfbl Number Of Distinct Categories Of Loans
NumberOfDistinctCategoriesOfLoans
2
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.4
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.55
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
CY2023Q3 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div><span style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Reclassification</span> <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Certain financial statement balances included in the prior year consolidated financial statements have been reclassified to conform to the current period presentation.</div>
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5173000
CY2023Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
0
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
433000
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
3000
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5102000
CY2023Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
44736000
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
138000
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
4465000
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
40409000
CY2023Q3 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
72806000
CY2023Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
0
CY2023Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
15249000
CY2023Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
57557000
CY2023Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
42910000
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
80000
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3439000
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
39551000
CY2023Q2 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
74423000
CY2023Q2 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
0
CY2023Q2 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
13201000
CY2023Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
61222000
CY2023Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
44736000
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
40409000
CY2023Q3 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
72806000
CY2023Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
57557000
CY2023Q3 hfbl Available For Sale Securities Securities Purchased Amortized Cost
AvailableForSaleSecuritiesSecuritiesPurchasedAmortizedCost
2700000
CY2023Q3 hfbl Securities Sold
SecuritiesSold
0
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
1059000
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
12131000
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
3406000
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
17614000
CY2023Q3 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
0
CY2023Q3 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
0
CY2023Q3 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
15249000
CY2023Q3 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
55997000
CY2023Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
65
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
629000
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
11856000
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
2811000
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
18892000
CY2023Q2 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
215000
CY2023Q2 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
1859000
CY2023Q2 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
12987000
CY2023Q2 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
57818000
CY2023Q3 us-gaap Notes Receivable Gross
NotesReceivableGross
511847000
CY2023Q2 us-gaap Notes Receivable Gross
NotesReceivableGross
494830000
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5102000
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5173000
CY2023Q3 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
146000
CY2023Q2 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
164000
CY2023Q3 us-gaap Notes Receivable Net
NotesReceivableNet
506599000
CY2023Q2 us-gaap Notes Receivable Net
NotesReceivableNet
489493000
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5173000
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4451000
CY2023Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
0
CY2023 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
868000
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
433000
CY2023 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
237000
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
3000
CY2023 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
91000
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5102000
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5173000
CY2023Q3 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
140649000
CY2023Q3 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
109808000
CY2023Q3 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
101195000
CY2023Q3 us-gaap Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
57764000
CY2023Q3 us-gaap Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
12507000
CY2023Q3 us-gaap Financing Receivable Originated Five Or More Years Before Latest Fiscal Year
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
21986000
CY2023Q3 us-gaap Financing Receivable Revolving
FinancingReceivableRevolving
67938000
CY2023Q3 us-gaap Notes Receivable Gross
NotesReceivableGross
511847000
CY2023Q3 us-gaap Financing Receivable Year One Originated Current Fiscal Year Writeoff
FinancingReceivableYearOneOriginatedCurrentFiscalYearWriteoff
5000
CY2023Q3 us-gaap Financing Receivable Year Two Originated Fiscal Year Before Current Fiscal Year Writeoff
FinancingReceivableYearTwoOriginatedFiscalYearBeforeCurrentFiscalYearWriteoff
428000
CY2023Q3 us-gaap Financing Receivable Year Three Originated Two Years Before Current Fiscal Year Writeoff
FinancingReceivableYearThreeOriginatedTwoYearsBeforeCurrentFiscalYearWriteoff
0
CY2023Q3 us-gaap Financing Receivable Year Four Originated Three Years Before Current Fiscal Year Writeoff
FinancingReceivableYearFourOriginatedThreeYearsBeforeCurrentFiscalYearWriteoff
0
CY2023Q3 us-gaap Financing Receivable Year Five Originated Four Years Before Current Fiscal Year Writeoff
FinancingReceivableYearFiveOriginatedFourYearsBeforeCurrentFiscalYearWriteoff
0
CY2023Q3 us-gaap Financing Receivable Originated More Than Five Years Before Current Fiscal Year Writeoff
FinancingReceivableOriginatedMoreThanFiveYearsBeforeCurrentFiscalYearWriteoff
0
CY2023Q3 us-gaap Financing Receivable Revolving Writeoff
FinancingReceivableRevolvingWriteoff
0
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
433000
CY2023Q2 us-gaap Notes Receivable Gross
NotesReceivableGross
494830000
CY2023Q3 us-gaap Notes Receivable Gross
NotesReceivableGross
511847000
CY2023Q3 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
68000
CY2023Q2 us-gaap Notes Receivable Gross
NotesReceivableGross
494830000
CY2023Q2 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0
CY2023Q3 us-gaap Loans And Leases Receivable Impaired Interest Income Recognized Change In Present Value Attributable To Passage Of Time
LoansAndLeasesReceivableImpairedInterestIncomeRecognizedChangeInPresentValueAttributableToPassageOfTime
0
CY2023Q2 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
0
CY2023Q3 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
0
CY2023 us-gaap Loans And Leases Receivable Impaired Interest Income Recognized Change In Present Value Attributable To Passage Of Time
LoansAndLeasesReceivableImpairedInterestIncomeRecognizedChangeInPresentValueAttributableToPassageOfTime
0
CY2023Q3 us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
102000
CY2023 us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
182000
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5173000
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
433000
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
3000
CY2023Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
0
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5102000
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4451000
CY2023 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
237000
CY2023 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
91000
CY2023 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
868000
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5173000
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
628000
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
4545000
CY2023Q2 us-gaap Notes Receivable Gross
NotesReceivableGross
494830000
CY2023Q2 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
7127000
CY2023Q2 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
487703000
CY2023Q3 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
11962000
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
148000
CY2023Q2 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
7127000
CY2023Q2 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
878000
CY2023Q2 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
6249000
CY2023Q2 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
7127000
CY2023Q2 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
628000
CY2023 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
8818000
CY2023Q3 hfbl Mortgage Loans In Process Of Foreclosure Number
MortgageLoansInProcessOfForeclosureNumber
0
CY2023 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
1
CY2023Q2 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
10000
CY2023Q3 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0
CY2023Q3 us-gaap Financing Receivable Accrued Interest After Allowance For Credit Loss
FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss
1700000
CY2023Q2 us-gaap Financing Receivable Accrued Interest After Allowance For Credit Loss
FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss
1600000
CY2023Q3 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
146057000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1220000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1671000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3029000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3066000
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
79000
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
162000
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3108000
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3228000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.4
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.55
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
CY2023Q3 hfbl Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number During Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberDuringPeriod
364916
CY2022Q3 hfbl Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number During Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberDuringPeriod
389616
CY2023Q3 hfbl Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price During Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceDuringPeriod
11.65
CY2022Q3 hfbl Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price During Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceDuringPeriod
11.81
CY2023Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
6125000
CY2022Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
6125000
CY2023Q3 us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
102000
CY2022Q3 us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
125000
CY2023Q3 us-gaap Weighted Average Number Of Shares Treasury Stock
WeightedAverageNumberOfSharesTreasuryStock
2994000
CY2022Q3 us-gaap Weighted Average Number Of Shares Treasury Stock
WeightedAverageNumberOfSharesTreasuryStock
2934000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3029000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3066000
CY2023Q3 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
4200000
CY2023Q2 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
4400000

Files In Submission

Name View Source Status
0001140361-23-052977-index-headers.html Edgar Link pending
0001140361-23-052977-index.html Edgar Link pending
0001140361-23-052977.txt Edgar Link pending
0001140361-23-052977-xbrl.zip Edgar Link pending
ef20012501_10q.htm Edgar Link pending
ef20012501_ex31-1.htm Edgar Link pending
ef20012501_ex31-2.htm Edgar Link pending
ef20012501_ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hfbl-20230930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
ef20012501_10q_htm.xml Edgar Link completed
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
hfbl-20230930_cal.xml Edgar Link unprocessable
hfbl-20230930_def.xml Edgar Link unprocessable
hfbl-20230930_pre.xml Edgar Link unprocessable
hfbl-20230930_lab.xml Edgar Link unprocessable